Apogee Therapeutics (APGE) Assets Average (2023 - 2026)

Apogee Therapeutics (APGE) has 4 years of Assets Average data on file, last reported at $1.1 billion in Q1 2026.

• On a quarterly basis, Assets Average rose 51.95% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 51.95% increase from a year earlier, with the FY2025 full-year figure at $845.5 million, up 46.37% from the prior year.
• Assets Average for Q1 2026 stood at $1.1 billion, up from $781.6 million in the prior quarter.
• Over the last five years, Assets Average for APGE reached as high as $1.1 billion in Q1 2026 and fell as low as $278.5 million in Q3 2023.
• Historically, Assets Average has averaged $693.6 million across 4 years, with a median of $734.1 million in 2025.
• Across the five-year window, Assets Average soared 183.07% in 2024 and fell 18.58% in 2025, its largest moves.
• Year by year, Assets Average stood at $413.9 million in 2023, then soared by 84.85% to $765.1 million in 2024, then advanced by 2.16% to $781.6 million in 2025, then jumped by 42.7% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $1.1 billion in Q1 2026, $781.6 million in Q4 2025, and $642.0 million in Q3 2025.